Impact of Pre-Analytical Variables on Cancer Targeted Gene Sequencing Efficiency-Reference-Cited by-同舟云学术

Impact of Pre-Analytical Variables on Cancer Targeted Gene Sequencing Efficiency

Published:2015-11-25 Issue:11 Volume:10 Page:e0143092
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Araujo Luiz H.,Timmers Cynthia,Shilo Konstantin,Zhao Weiqiang,Zhang Jianying,Yu Lianbo,Natarajan Thanemozhi G.,Miller Clinton J.,Yilmaz Ayse Selen,Liu Tom,Amann Joseph,Lapa e Silva José Roberto,Ferreira Carlos Gil,Carbone David P.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. Clinical implications of the cancer genome;LE Macconaill;Journal of clinical oncology: official journal of the American Society of Clinical Oncology,2010

2. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor;MC Heinrich;Journal of clinical oncology: official journal of the American Society of Clinical Oncology,2003

3. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;TJ Lynch;The New England journal of medicine,2004

4. Mutations of the BRAF gene in human cancer;H Davies;Nature,2002

5. Cancer genome landscapes;B Vogelstein;Science,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Resolution Genotyping of Formalin-Fixed Tissue Accurately Estimates Polygenic Risk Scores in Human Diseases;Laboratory Investigation;2024-04

2. The role of plasma genotyping in ALK- and ROS1-rearranged lung cancer;TRANSL LUNG CANCER R;2020

3. Junction Location Identifier (JuLI);The Journal of Molecular Diagnostics;2020-03

4. In search of an evidence-based strategy for quality assessment of human tissue samples: report of the tissue Biospecimen Research Working Group of the Spanish Biobank Network;Journal of Translational Medicine;2019-11-12

5. JuLI: accurate detection of DNA fusions in clinical sequencing for precision oncology;2019-01-16